Elanco Animal Health (ELAN) Cash & Current Investments (2017 - 2026)

Elanco Animal Health has reported Cash & Current Investments for 10 years, with the latest figure at $428.0 million in Q1 2026.

• Quarterly Cash & Current Investments fell 12.11% year-over-year to $428.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $428.0 million (down 12.11% YoY) and the FY2025 annual result came in at $545.0 million, up 16.45% from the prior year.
• Cash & Current Investments retreated to $428.0 million in Q1 2026 per ELAN's latest filing, from $545.0 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $545.0 million in Q4 2025 and troughed at $318.0 million in Q1 2023.
• A 5-year average of $428.4 million and a median of $428.0 million in 2026 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2025: Cash & Current Investments slumped 45.92% in 2022, then jumped 41.16% in 2025.
• Over 5 years, Cash & Current Investments stood at $345.0 million in 2022, then advanced by 2.03% to $352.0 million in 2023, then surged by 32.95% to $468.0 million in 2024, then rose by 16.45% to $545.0 million in 2025, then decreased by 21.47% to $428.0 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $428.0 million, $545.0 million, and $505.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.